ofa lawsuit semaglutide The FDA sent a warning letter this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, potential side effects in patients who took its popular medications containing Two lawsuits regarding competition violations

it must be administered subcutaneously only Never share your Wegovy pen with another person, even if the needle is changed Do not inject through clothing If you experience persistent pain, significant bruising, or signs of infection (redness, warmth, swelling), contact your GP or prescribing clinician Never inject into areas with skin changes, bruises, or scarring Proper disposal of used pens in a sharps container is essential for safety

Morris VK, Overman MJ, Maru DM, Kopetz S

The CIR (Cosmetic Ingredient Review) has concluded this ingredient to be safe as used in cosmetics and it has not shown to be a skin sensitizer in testing (unless you have a known rice allergy)

Others are pure marketing hype